Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
Skip to content GLP-1 What Most GLP-1 Programs Dont Plan ForAnd How We Do It Differently Stefani Hillin2026-05-11T17:50:30-06:00 GLP-1 medications like Semaglutide and Tirzepatide have changed the conversation around weight loss
The SURMOUNT-5 trial, published in The New England Journal of Medicine , directly compared tirzepatide to semaglutide and found tirzepatide produced 47% greater relative weight loss at 72 weeks, 20.2% of body weight versus 13.7%
Lenzi A, Sgr P, Salacone P, Paoli D, Gilio B, Lombardo F, et al
The US FDA granted olezarsen an Orphan Drug designation in 2023 for the treatment of familial chylomicronemia syndrome (FCS).
PubMed 23755725 Sikiric P, Rucman R, Turkovic B, et al
US$ 24.41
US$ 28.92
US$ 28.57
